Background Image
Table of Contents Table of Contents
Previous Page  19 / 84 Next Page
Information
Show Menu
Previous Page 19 / 84 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 2, March/April 2018

AFRICA

81

Multimedia Sourcebook, MONICA Project. Geneva: World Health

Organization, 2003.

4.

Yusuf S, Hawken S, Ounpuu S,

et al

. Effect of potentially modifiable

risk factors associated with myocardial infarction in 52 countries (the

INTERHEART study): case-control study.

Lancet

2004;

364

: 937–952.

5.

Steyn K, Sliwa K, Hawken S,

et al

. Risk factors associated with myocar-

dial infarction in Africa: the INTERHEART Africa study.

Circulation

2005;

112

(23): 3554–3561.

6.

World Health Organization.

Global action plan for the prevention and

control of noncommunicable diseases 2013–2020

. Geneva: World Health

Organization, 2013.

7.

Kontis V, Mathers CD, Bonita R,

et al

. Regional contributions of six

preventable risk factors to achieving the 25 × 25 non-communicable

disease mortality reduction target: a modelling study.

Lancet Glob

Health

2015;

3

: e746–57. doi: 10.1016/S2214-109X(15)00179-5.

8.

Mocumbi AO. Lack of focus on cardiovascular disease in sub-Saha-

ran Africa.

Cardiovasc Diagn Ther

2012;

2

(1): 74–77. doi: 10.3978/j.

issn.2223-3652.2012.01.03.

9.

Kroll M, Phalkey RK, Kraas F. Challenges to the surveillance of non-

communicable diseases – a review of selected approaches.

BMC Public

Health

2015;

15

: 1243. doi: 10.1186/s12889-015-2570-z.

10. Dalal S, Beunza JJ, Volmink J,

et al.

Non-communicable diseases in sub-

Saharan Africa: what we know now.

Int J Epidemiol

2011;

40

: 885–901.

doi: 10.1093/ije/dyr050.

11. World Health Organization.

The STEPS Instrument and Support

Materials

. Available from:

http://www.who.int/chp/steps/instrument/en/

[Accessed November 20, 2016].

12. GBD 2015 Mortality and Causes of Death Collaborators. Global,

regional, and national life expectancy, all-cause mortality, and cause-

specific mortality for 249 causes of death, 1980–2015: a systematic

analysis for the Global Burden of Disease Study 2015.

Lancet

2016;

388

:

1459–544. doi: 10.1016/S0140-6736(16)31012-1.

13. World Health Organization.

Noncommunicable Diseases Country

Profiles 2014

. Geneva: World Health Organization, 2014.

14. Simão M, Hayashida M, Santos CB,

et al.

Hypertension among under-

graduate students from Lubango, Angola.

Rev Latino-am Enfermagem

2008;

16

(4): 672–678.

15. Capingana DP, Magalhães P, Silva ABT,

et al.

Prevalence of cardiovas-

cular risk factors and socioeconomic level among public-sector workers

in Angola.

BMC Public Health

2013;

13

: 732. doi: 10.1186/1471-2458-

13-732.

16. Pires JE, Sebastião YV, Langa AJ,

et al

. Hypertension in Northern

Angola: prevalence, associated factors, awareness, treatment and

control.

BMC Public Health

2013;

13

: 90. doi: 10.1186/1471-2458-13-90.

17. Evaristo-Neto AD, Foss-Freitas MC, Foss, MC. Prevalence of diabe-

tes mellitus and impaired glucose tolerance in a rural community of

Angola.

Diabetol Metab Syndr

2010;

2

: 63. doi: 10.1186/1758-5996-2-63.

18. Costa MJ, Rosário E, Langa AJ,

et al.

Setting up a demographic surveil-

lance system in northern Angola.

Afr Pop Stud J

2012;

26

: 2.

19. Pedro JM, Rosario E, Brito M,

et al.

CardioBengo Study Protocol: a

population based cardiovascular longitudinal study in Bengo Province,

Angola.

BMC Public Health

2016;

16

: 206. 10.1186/s12889-016-2759-9.

20. World Health Organization. Obesity: preventing and managing the

global epidemic. Report of a WHO consultation.

World Health Organ

Tech Rep Ser

2000;

894

: 1–253.

21. World Health Organization.

Waist circumference and waist–hip ratio:

Report of a WHO Expert Consultation, 2008

. Geneva: World Health

Organization, 2008.

22. Weber MA, Schiffrinb EL, Whitec WB,

et al.

Clinical practice guidelines

for the management of hypertension in the community – a statement by

the American Society of Hypertension and the International Society of

Hypertension.

J Clin Hypertens (Greenwich)

2014;

16

(1): 14–26. doi:

10.1111/jch.12237.

23. World Health Organization.

Definition and diagnosis of diabetes mellitus

and intermediate hyperglycaemia: report of a WHO/IDF consultation

.

Geneva: World Health Organization, 2006.

24. Guwatudde D, Nankya-Mutyoba J, Kalyesubula R,

et al.

The burden

of hypertension in sub-Saharan Africa: a four-country cross sectional

study.

BMC Public Health

2015;

15

: 1211. doi: 10.1186/s12889-015-

2546-z.

25. Mensah, GA. Descriptive epidemiology of cardiovascular risk factors

and diabetes in sub-Saharan Africa.

Prog Cardiovasc Dis

2013;

56

(3):

240–250. doi: 10.1016/j.pcad.2013.10.014.

26. World Health Organization.

STEPS Country Reports

. Available from:

http://www.who.int/chp/steps/reports/en/.

[Accessed November 20,

2016].

27. NCD Risk Factor Collaboration. Worldwide trends in diabetes since

1980: a pooled analysis of 751 population-based studies with 4.4

million participants.

Lancet

2016;

387

: 1513–1530. doi: 10.1016/S0140-

6736(16)00618-8.

28. Popkin BM, Adair LS, Ng SW. Now and then: the global nutrition tran-

sition: the pandemic of obesity in developing countries.

Nutr Rev

2012;

70

(1): 3–21. doi: 10.1111/j.1753-4887.2011.00456.x.

29. N Mbanya JC, Motala AA, Sobngwi E,

et al.

Diabetes in sub-

Saharan Africa.

Lancet

2010;

375

: 2254–2266. doi: 10.1016/S0140-

6736(10)60550-8.

30. Hall V, Thomsen RW, Henriksen O,

et al.

Diabetes in sub-Saharan

Africa 1999–2011: Epidemiology and public health implications. A

systematic review.

BMC Public Health

2011;

11

: 564. doi: 10.1186/1471-

2458-11-564.

31. Hilawe EH, Yatsuya H, Kawaguchia L,

et al.

Differences by sex in the

prevalence of diabetes mellitus, impaired fasting glycaemia and impaired

glucose tolerance in sub-Saharan Africa: a systematic review and meta-

analysis.

Bull World Health Organ

2013;

91

: 671–682D. doi: 10.2471/

BLT.12.113415.

32. Adeloye D, Basquill C. Estimating the prevalence and awareness rates

of hypertension in Africa: a systematic analysis.

PLoS ONE

2014;

9

(8):

e104300. doi: 10.1371/journal.pone.0104300.

33. Kayima J, Wanyenze RK, Katamba A,

et al.

Hypertension awareness,

treatment and control in Africa: a systematic review.

BMC Cardiovasc

Disord

2013;

13

: 54. doi: 10.1186/1471-2261-13-54.

34. Pereira M, Lunet N, Azevedo A,

et al.

Differences in prevalence, aware-

ness, treatment and control of hypertension between developing and

developed countries.

J Hypertens

2009;

27

: 963–975.

35. Independent Task Force on Noncommunicable Diseases.

The emerging

global health crisis: noncommunicable diseases in low and middle-income

countries.

Independent Task Force report no 72. New York: Council on

Foreign Relations Press, 2014.

36. Manne-Goehler J, Atun R, Stokes A,

et al.

Diabetes diagnosis and

care in sub-Saharan Africa: pooled analysis of individual data from

12 countries.

Lancet Diabetes Endocrinol

2016. doi: 10.1016/S2213-

8587(16)30181-4.